Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
62.6M
-
Shares change
-
-1.07M
-
Total reported value, excl. options
-
$200M
-
Value change
-
-$3.09M
-
Put/Call ratio
-
0.91
-
Number of buys
-
59
-
Number of sells
-
-48
-
Price
-
$3.20
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q4 2024
136 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q4 2024.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.6M shares
of 127M outstanding shares and own 49.31% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (12.5M shares), MORGAN STANLEY (11.8M shares), BlackRock, Inc. (5.28M shares), VANGUARD GROUP INC (3.59M shares), ACADIAN ASSET MANAGEMENT LLC (3.08M shares), Assenagon Asset Management S.A. (2.95M shares), DIMENSIONAL FUND ADVISORS LP (2.79M shares), DEUTSCHE BANK AG\ (2.45M shares), GEODE CAPITAL MANAGEMENT, LLC (1.74M shares), and STATE STREET CORP (1.55M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.